De novo subtype and strain identification of botulinum neurotoxin type B through toxin proteomics.
about
Mass Spectrometric Detection of Bacterial Protein Toxins and Their Enzymatic ActivityCharacterization of Hemagglutinin Negative Botulinum Progenitor Toxins.Epitope mapping of botulinum neurotoxins light chains.Analysis of a unique Clostridium botulinum strain from the Southern hemisphere producing a novel type E botulinum neurotoxin subtype.Genomic and physiological variability within Group II (non-proteolytic) Clostridium botulinum.Isolation and functional characterization of the novel Clostridium botulinum neurotoxin A8 subtype.Validation of the Endopep-MS method for qualitative detection of active botulinum neurotoxins in human and chicken serum.A simple, rapid and sensitive FRET assay for botulinum neurotoxin serotype B detection.Development of human-like scFv-Fc antibodies neutralizing Botulinum toxin serotype BThree enzymatically active neurotoxins of Clostridium botulinum strain Af84: BoNT/A2, /F4, and /F5Mass Spectrometric Identification and Differentiation of Botulinum Neurotoxins through Toxin Proteomics.Qualitative and Quantitative Detection of Botulinum Neurotoxins from Complex Matrices: Results of the First International Proficiency Test.Recommended Immunological Strategies to Screen for Botulinum Neurotoxin-Containing Samples.Molecular characterization of Clostridium botulinum isolates from foodborne outbreaks in Thailand, 2010.Characterization of botulinum neurotoxin type A subtypes by immunocapture enrichment and liquid chromatography-tandem mass spectrometry.Two Feet on the Membrane: Uptake of Clostridial Neurotoxins.Bacterial Toxins - Structure, Properties and Mode of Action
P2860
Q26781284-C937966D-D818-4828-9290-D7C4605E0A65Q33845176-F6003CEE-2DDE-44BA-95AC-FD6A7BEA8C23Q34393419-FEC2A4E6-9534-40C5-933E-A9F7A39C3EF3Q34462614-D9D17D60-3D1C-4475-ACAE-5D62B7EB3816Q34725616-71D6E7B9-52BA-4799-8301-C5DAD0CA2562Q35058841-B62AA302-8392-4F14-9409-D75AF77F65E3Q35257144-B1A69A0C-387E-4B6D-965D-EF22E1F79B82Q35463149-D9AC5786-B7F8-4E43-A38E-720A842B6B82Q35779652-D1EC35A8-52AD-4E60-AAD1-E7744125375EQ35910517-FA7A603D-0289-43C0-8B95-F5A5BC18346FQ35995602-D4272EA8-84FD-410E-8764-57E05BB05235Q36401410-6EE9CF3B-9925-4CFB-9C05-EFECF8D46A16Q36401421-B8F12163-7537-45E8-9B0E-A269ECFA1CD8Q37521567-B4671176-F3EA-4EF7-99BC-BB41D9ACE806Q40874988-C1945B1B-48F0-454D-B837-F04FB0E8F4AEQ48026258-4BA0E849-713F-40AE-8337-8407394335FAQ58834190-D1E7B480-2008-4D29-8207-AFB23A5274F2
P2860
De novo subtype and strain identification of botulinum neurotoxin type B through toxin proteomics.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
De novo subtype and strain ide ...... pe B through toxin proteomics.
@ast
De novo subtype and strain ide ...... pe B through toxin proteomics.
@en
type
label
De novo subtype and strain ide ...... pe B through toxin proteomics.
@ast
De novo subtype and strain ide ...... pe B through toxin proteomics.
@en
prefLabel
De novo subtype and strain ide ...... pe B through toxin proteomics.
@ast
De novo subtype and strain ide ...... pe B through toxin proteomics.
@en
P2093
P2860
P1476
De novo subtype and strain ide ...... ype B through toxin proteomics
@en
P2093
Brigitte G Dorner
Charles H Helma
Jakub Baudys
James L Pirkle
John R Barr
Jon C Rees
Karen Hill
Leonard A Smith
Martin B Dorner
Skadi Kull
P2860
P2888
P304
P356
10.1007/S00216-012-5767-3
P407
P577
2012-03-07T00:00:00Z